October 30th, 2020
Read ArticleOctober 30th, 2020
Read ArticleOctober 23rd, 2020Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD,...
Read ArticleOctober 21st, 2020Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina...
Read ArticleOctober 20th, 2020Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm - 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma...
Read ArticleOctober 19th, 2020The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD Jonathan Trent, M.D., Ph.D. is a world...
Read ArticleOctober 16th, 2020Sarcomas: Evidence-Based Diagnosis and Management Jonathan C. Trent, Andrew E. Rosenberg, Raphael Pollock, Thomas F. Delaney Springer Publishing Company, Incorporated, 2020 - Medical - 434 pages Jonathan Trent, M.D.,Ph.D. is the leader of the...
Read ArticleOctober 15th, 2020Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm - 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma...
Read ArticleOctober 12th, 2020Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm - 8:30pm Easter Standard Time For CS Warriors who have been newly diagnosed, for CS Warriors that have been diagnosed with a reoccurrence of...
Read Article